Fig. 3
From: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Progression-free survival in patients with normal and elevated CEA levels.
Fig. 3 | Scientific Reports
From: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Progression-free survival in patients with normal and elevated CEA levels.
